dr berg semaglutide Obesity Doctor reacts to Eric “This is better than Ozempic” #glp1 #weightloss The Best MOUNJARO Alternative (Without

[15] [37] [38] In August 2025, the Food and Drug Administration (FDA) expanded the indication for semaglutide (as Wegovy) to include the treatment of noncirrhotic metabolic-associated steatohepatitis (MASH), formerly known as nonalcoholic steatohepatitis (NASH), with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis) in adults

Airport security questions your injectable medication if its not properly labeled

These conditions put you at risk for heart disease, and losing weight is often a crucial part of controlling or even reversing these health issues

Anti-obesity medications continue to gain momentum To fully understand where obesity treatment is headed, it helps to look at where it all began

PCOS patients should note that semaglutide's appetite suppression may lower calorie intake substantially